Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
US6071934A · kind A · utility
15Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 1997 |
| Grant date | Jun 6, 2000 |
| Priority date | — |
| Expiry date | Mar 25, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes are useful in the treatment of precancerous lesions and neoplasms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.